Virus

Photo

News • Outbreak response study

Hepatitis E vaccination: 2 out of 3 doses still effective in an epidemic

The vaccine to protect against Hepatitis E is given in a 3-dose regimen. However, in an epidemic setting, two doses have also proven effective, a new study shows.

Photo

News • Potential for neurodegeneration

Head injuries may activate dormant viruses, trigger neurodegeneration, study finds

More than just a sports injury: A new study shows that head trauma may activate latent viruses, leading to neurodegenerative conditions such as Alzheimer’s disease and Parkinson’s disease.

Photo

News • Surprising insights

Herpes infection might drive Alzheimer's, study suggests

Researchers uncovered a surprising link between Alzheimer’s disease and herpes simplex virus-1 (HSV-1), suggesting that viral infections may play a role in the disease.

Photo

News • Human papillomavirus infection

Cervical cancer: improved screening through HPV risk groups

Analyses of self-tests for human papillomavirus (HPV) can be used to divide HPV-positive women into three risk groups, according to a new study. This could enhance cervical cancer screening.

Photo

News • Inhibition of Sars-CoV-2 proliferation

New 'hairpin' tool stops coronavirus in its tracks

A new way to inhibit the proliferation of Sars-CoV-2 opens up new perspectives in the fight against this coronavirus and other viral diseases that still have no medical treatment.

Photo

News • Study on antiviral therapy efficacy

Covid-19 treatment of immunocompromised patients: better late than never

Immunocompromised patients are at greatest risk of developing severe Covid-19 after an infection. While early antiviral treatments yield best results, even late-onset therapies still show benefits.

282 show more articles
Subscribe to Newsletter